Skip to content

Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block

Effect of Anesthetic Choice (Sevoflurane Versus Desflurane) on Speed and Sustained Nature of Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01199237
Enrollment
107
Registered
2010-09-10
Start date
2010-08-31
Completion date
2013-08-31
Last updated
2014-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Reflexes, Protective, Anesthetic Recovery, Recovery After Neuromuscular Block

Keywords

Reflex, Pharyngeal, Anesthetics, Inhalation

Brief summary

Protective airway reflexes may be impaired in the postoperative period, creating the potential for aspiration of gastric contents, even after a patient exhibits appropriate response to command. Because assessment of airway reflex recovery is not possible in an intubated patient, the clinician must make an empiric decision as to when a patient is safe to extubate, and choose a combination of techniques least likely to result in pharyngeal impairment. Adequacy of reversal of neuromuscular block by cholinesterase inhibitors (e.g., neostigmine) is unpredictable, especially in the presence of profound paralysis, and tactile assessment of train-of four and sustained tetanus has shown poor correlation with objective assessments. Protective airway reflexes may also be impaired during early recovery by the anesthetics themselves, even when muscle relaxant has been avoided. In the absence of muscle relaxant the investigators previously demonstrated that patients receiving an anesthetic with higher tissue solubility, sevoflurane showed significantly greater impairment of swallowing up to 14 minutes after response to command compared to patients receiving an anesthetic with lower tissue solubility, desflurane. Therefore, we ask whether the combination of the more soluble anesthetic and the presence of neuromuscular block antagonized by neostigmine may create a multiplicative effect that might further prolong pharyngeal recovery. We plan to randomly assign 100 patients scheduled to undergo surgery with general anesthesia to a standardized anesthetic that includes 1) sevoflurane, rocuronium with 70 µg/kg neostigmine + 14 µg/kg glycopyrrolate antagonism (group S); or 2) desflurane, rocuronium with 70 µg/kg neostigmine + 14 µg/kg glycopyrrolate antagonism (group D). Airway reflex recovery will be judged as adequate by the patient's ability to swallow 20 mL of water without coughing or drooling 5, 10, 15, 20, 30 and 60 minutes after response to command. Anesthetic (sevoflurane or desflurane) will be discontinued after administration of reversal agent and recovery to TOF (train-of-four) ratio of 0.7.

Interventions

DRUGSevoflurane

Protective airway reflexes will be tested, judged by subject's ability to swallow 20 mL water

DRUGDesflurane

Protective airway reflexes will be tested, judged by subject's ability to swallow 20 mL water

DRUGRocuronium
DRUGNeostigmine
DRUGGlycopyrrolate

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ASA 1-2 patients * Age 18-65 years * body mass index (BMI) ≤ 35kg/m2 * Planned surgery requiring general anesthesia lasting approximately 1.5-3.0 hours * Surgery requires or benefits from skeletal muscle relaxation * All must pass the baseline 20 mL water swallowing test as previously described.

Exclusion criteria

* Pre-existing neuromuscular or central nervous system disorder * Known condition interfering with gastric emptying * Planned surgical procedure on the head or neck * Known liver disease * Serum creatinine \> 1.5 mg/dL * Concurrent use of neuroleptic medications * Contraindication or previous adverse response to any of the study drugs * Active asthma or reactive airways disease * Surgery where upright position or brief cough would be contraindicated * Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Recovery of Ability to Swallow After Neostigmine/Glycopyrrolate Antagonism of Rocuronium Paralysis.At 2 minutes after response to command (T1).The patient is judged by the primary anesthetist to be awake at time T1. At 2 minutes after T1, the patient was asked to swallow 20mL of water from a paper cup, and a blinded observer judged the ability to swallow based on transit of water to the posterior pharynx (absence of pooling or drooling) and absence of cough or gag.

Secondary

MeasureTime frameDescription
Time From Potent Inhaled Anesthetic Discontinuation to First Response to Command (T1)Up to 1 hour post-operativeAt the conclusion of surgery, after the patient's potent inhaled anesthetic was discontinued, the commands open your eyes and squeeze my hand were given at 30-second intervals. The time at which patient first appropriately response to both commands was noted as T1.
Nausea and Vomiting30 minutes after T1Patients were asked to rate their experience of nausea and vomiting on a 0-10 verbal analog scale, with 0 being absence and 10 being the worst imaginable
Time From Anesthetic Discontinuation to First Ability to Swallowup to 60 minutes after T1At 2 minutes after first response to command (T1), the patient was asked to swallow 20 mL of water from a paper cup, and an observer blinded to anesthetic assignment assessed the ability to swallow based on transit of water to the posterior pharynx (absence of pooling or drooling) and absence of cough or gag (indicating misdirection of the water bolus into the laryngeal inlet). This test was repeated at 6, 14, 22, 30 and 60 minutes after the time of first response to command.

Countries

United States

Participant flow

Recruitment details

At one U.S. clinical site, patients scheduled to undergo surgery requiring general anesthesia lasting approximately 1.5 - 3.0 hours requiring tracheal intubation and paralysis during surgery were invited to participate

Pre-assignment details

Participation of the first 26 enrollees was considered a pilot to determine the feasibility of measuring the primary outcome at T1+5 minutes. The majority of participants were alert, and no meaningful analyses could be made. The study was modified to assess the primary outcome at T1 + 2 minutes, and 81 additional participants were recruited.

Participants by arm

ArmCount
Sevoflurane
Patients received sevoflurane, rocuronium with neostigmine + glycopyrrolate reversal (70 and 14 ug/kg)
41
Desflurane
Patients received Desflurane, rocuronium with neostigmine + glycopyrrolate reversal (70 and 14 ug/kg)
40
Total81

Baseline characteristics

CharacteristicSevofluraneDesfluraneTotal
Age, Continuous45.3 years43.3 years44.3 years
Region of Enrollment
United States
41 participants40 participants81 participants
Sex: Female, Male
Female
41 Participants36 Participants77 Participants
Sex: Female, Male
Male
0 Participants4 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 410 / 40
serious
Total, serious adverse events
0 / 410 / 40

Outcome results

Primary

Recovery of Ability to Swallow After Neostigmine/Glycopyrrolate Antagonism of Rocuronium Paralysis.

The patient is judged by the primary anesthetist to be awake at time T1. At 2 minutes after T1, the patient was asked to swallow 20mL of water from a paper cup, and a blinded observer judged the ability to swallow based on transit of water to the posterior pharynx (absence of pooling or drooling) and absence of cough or gag.

Time frame: At 2 minutes after response to command (T1).

Population: Only participants judged by the clinician as able to take the test (n=57)

ArmMeasureGroupValue (NUMBER)
SevofluraneRecovery of Ability to Swallow After Neostigmine/Glycopyrrolate Antagonism of Rocuronium Paralysis.able to swallow at T1+2 minutes16 participants
SevofluraneRecovery of Ability to Swallow After Neostigmine/Glycopyrrolate Antagonism of Rocuronium Paralysis.unable to swallow at T1+2 minutes10 participants
DesfluraneRecovery of Ability to Swallow After Neostigmine/Glycopyrrolate Antagonism of Rocuronium Paralysis.able to swallow at T1+2 minutes25 participants
DesfluraneRecovery of Ability to Swallow After Neostigmine/Glycopyrrolate Antagonism of Rocuronium Paralysis.unable to swallow at T1+2 minutes6 participants
p-value: 0.11Chi-squared
Secondary

Nausea and Vomiting

Patients were asked to rate their experience of nausea and vomiting on a 0-10 verbal analog scale, with 0 being absence and 10 being the worst imaginable

Time frame: 30 minutes after T1

Population: Only participants able to respond at time of assessment

ArmMeasureGroupValue (MEAN)
SevofluraneNausea and VomitingNausea0.385 units on a scale
SevofluraneNausea and VomitingVomiting0 units on a scale
DesfluraneNausea and VomitingNausea1.359 units on a scale
DesfluraneNausea and VomitingVomiting0 units on a scale
Secondary

Nausea and Vomiting

Patients were asked to rate their experience of nausea and vomiting on a 0-10 verbal analog scale, with 0 being absence and 10 being the worst imaginable

Time frame: 60 minutes after T1

Population: Only patients able to respond at time of assessment

ArmMeasureGroupValue (MEAN)
SevofluraneNausea and VomitingNausea0.263 units on a scale
SevofluraneNausea and VomitingVomiting0 units on a scale
DesfluraneNausea and VomitingNausea1.333 units on a scale
DesfluraneNausea and VomitingVomiting0.026 units on a scale
Secondary

Time From Anesthetic Discontinuation to First Ability to Swallow

At 2 minutes after first response to command (T1), the patient was asked to swallow 20 mL of water from a paper cup, and an observer blinded to anesthetic assignment assessed the ability to swallow based on transit of water to the posterior pharynx (absence of pooling or drooling) and absence of cough or gag (indicating misdirection of the water bolus into the laryngeal inlet). This test was repeated at 6, 14, 22, 30 and 60 minutes after the time of first response to command.

Time frame: up to 60 minutes after T1

ArmMeasureValue (MEAN)
SevofluraneTime From Anesthetic Discontinuation to First Ability to Swallow1275 Seconds
DesfluraneTime From Anesthetic Discontinuation to First Ability to Swallow718 Seconds
Secondary

Time From Potent Inhaled Anesthetic Discontinuation to First Response to Command (T1)

At the conclusion of surgery, after the patient's potent inhaled anesthetic was discontinued, the commands open your eyes and squeeze my hand were given at 30-second intervals. The time at which patient first appropriately response to both commands was noted as T1.

Time frame: Up to 1 hour post-operative

ArmMeasureValue (MEAN)
SevofluraneTime From Potent Inhaled Anesthetic Discontinuation to First Response to Command (T1)623 seconds
DesfluraneTime From Potent Inhaled Anesthetic Discontinuation to First Response to Command (T1)343 seconds

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026